Organization · Venture Capital
NovaQuest Capital Management
NovaQuest Capital Management is a life science investment firm based in Raleigh, North Carolina, specializing in biopharmaceuticals and animal healthcare. The firm focuses on providing non-dilutive capital solutions to support late-stage drug development.
Overview
What NovaQuest Capital Management does
What NovaQuest Capital Management is
NovaQuest Capital Management is a life science investment firm based in Raleigh, North Carolina, specializing in biopharmaceuticals and animal healthcare. The firm focuses on providing non-dilutive capital solutions to support late-stage drug development.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2010
- Approximate age
- About 16 years
- Structured capabilities
- Funder
- Last reviewed
- May 4, 2026
Official channels
Find NovaQuest Capital Management elsewhere
Open the official website or a supported primary organization account.
Capability profile
NovaQuest Capital Management as a funder
Investment thesis
NovaQuest Capital Management focuses on providing tailored capital solutions through its proprietary PRODUCT FINANCE™ model, supporting late-stage clinical trials and product launches in biopharmaceuticals and animal health without equity dilution.
Focus narrative
NovaQuest invests primarily in the biopharmaceutical and animal health sectors. Their investment strategies include late-stage PRODUCT FINANCE™ investments in global biopharmaceutical products and partnerships with companies developing pharmaceuticals, vaccines, and technologies for companion and production animals. The firm employs a structured finance model, offering non-dilutive and non-controlling investment structures to support pivotal clinical trials and product launches.
Value beyond capital
NovaQuest adds value by providing non-dilutive capital solutions that allow portfolio companies to fund pivotal clinical trials and product launches without sacrificing equity. Their expertise in structured finance and deep industry knowledge helps guide companies through critical development stages.
Terms and economics
- Typical check
- $30,000,000–$100,000,000
Focus and fit
- Stages
- Series A · Growth Equity
- Regions
- Global · North America · Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include California Cryobank, which provides reproductive services; Gallant, focusing on stem cell therapies for pets; and Nerviano Medical Sciences, engaged in royalty agreements for biopharmaceutical products. Other significant investments include FibroGen, Cerevel, Dermavant, Myovant, and Pfizer.
Common questions
What to know about NovaQuest Capital Management
Upseed classifies NovaQuest Capital Management under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.